The Center for Disease Control and Preventions Advisory Committee on Immunization Practices held an emergency meeting on May 12th, 2021 to consider adding the Pfizer-BioNTech Covid-19 “vaccine” to the interim adolescent schedule for 12-15 year-olds.
Below is the public comment submitted by
Janci Chunn Lindsay, Ph.D.
